Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Breast 1

Conditions

Smoking Cessation 1Prostatic Neoplasms 1Lung Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 388Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Has results × Tea × Clear all
NCT01928485 2020-10-22

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Case Comprehensive Cancer Center

Phase 2 Terminated
6 enrolled 23 charts
Genitourinary

Prostatic Neoplasms

NCT01060345 2020-04-09

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

University of Chicago

Phase 2 Terminated
20 enrolled 5 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT00363805 2013-11-28

Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease

University of Arizona

Phase 2 Completed
178 enrolled 10 charts
Thoracic

Lung Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡